Previous studies showed that the expression of TEAD2 was enriched in the nucleus and directed a predominant nuclear localization of YAP via the formation of TEAD2-YAP complex in the process of epithelial-mesenchymal transition of breast cancer cells [28]. The gene discussed is TEAD2; the disease is breast cancer.